Literature DB >> 1360503

The plasma disposition and renal elimination of digoxin-specific Fab fragments and digoxin in the rabbit.

M P Timsina1, D S Hewick.   

Abstract

Administering digoxin-specific antibody fragments (DSFab, 1.9 mg kg-1, i.v.) to rabbits 1 h after digoxin (15 micrograms kg-1 or 12.5 microCi kg-1, i.v.) produced a redistribution of digoxin associated with a 5-fold elevation in total plasma concentration and 36-86% reductions in elimination half-life, apparent volume of distribution at steady-state and total body clearance (CLT). Renal clearance (CLR) was also reduced (54%), but urinary digoxin excretion was increased by one-third (35% vs 25%). This apparent anomaly is due to the large rise in total plasma digoxin concentration with a consequent increase in the area under the plasma concentration curve (AUC). The AUC, which is the denominator term in calculating CLR (and CLT), was increased to a greater extent than urinary digoxin excretion (numerator term in calculating CLR) so that an overall reduction in CLR occurred. The initial presence of digoxin appeared to alter the distribution of DSFab, since their plasma concentrations were markedly higher when the antibody was given after the hapten. The digoxin also reduced (from 3 to 1%) the amount of detectable DSFab in the urine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360503     DOI: 10.1111/j.2042-7158.1992.tb03208.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Antibodies as carrier proteins.

Authors:  B N Rehlaender; M J Cho
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

3.  Anti-drug antibodies as drug carriers. I. For small molecules.

Authors:  B N Rehlaender; M J Cho
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

4.  Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

Authors:  N J Cano; A E Sabouraud; K Benmoussa; F Roquet; I Navarro-Teulon; J C Mani; J M Scherrmann
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

5.  Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.

Authors:  S Pepin; C Lutsch; M Grandgeorge; J M Scherrmann
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.